Literature DB >> 4604215

Chemotherapy of experimental streptococcal endocarditis. 3. Failure of a bacteriostatic agent (tetracycline) in prophylaxis.

F S Southwick, D T Durack.   

Abstract

Bacteriostatic agents are frequently recommended as alternatives to penicillin for prophylaxis of bacterial endocarditis. To test the efficacy of this group of antimicrobials, prophylaxis of experimental streptococcal endocarditis was attempted with tetracycline. The number of streptococci colonizing the aortic valves of rabbits was not affected by inhibitory levels of tetracycline, but multiplication was checked. Streptococcis urvived in vegetations for seven days despite the continuous presence of tetracycline, and multiplied when the drug was withdrawn. It is therefore suggested that bacteriostatic agents may be valueless for prophylaxis of bacterial endocarditis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4604215      PMCID: PMC478098          DOI: 10.1136/jcp.27.4.261

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Prophylaxis of bacterial endocarditis.

Authors:  E W HOOK; D KAYE
Journal:  J Chronic Dis       Date:  1962-06

2.  The Rôle Played by Rheumatic Fever in the Implantation of Bacterial Endocarditis.

Authors:  L Gross; B M Fried
Journal:  Am J Pathol       Date:  1937-09       Impact factor: 4.307

3.  Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

4.  Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits.

Authors:  D T Durack; P B Beeson; R G Petersdorf
Journal:  Br J Exp Pathol       Date:  1973-04

5.  Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.

Authors:  D T Durack; R G Petersdorf
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

6.  Chlortetracycline (aureomycin) in prevention of bacteremia following oral surgery; attempt to prevent subacute bacterial endocarditis in patients with heart disease.

Authors:  O ROTH; G M MONTANO; J A PICCOLO; A L CAVALLARO; D C SHARKEY; R CELENTANO
Journal:  AMA Arch Intern Med       Date:  1953-10

7.  An effective antibiotic cover for the prevention of endocarditis following dental and other post-operative bacteraemias.

Authors:  O Khairat
Journal:  J Clin Pathol       Date:  1966-11       Impact factor: 3.411

8.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart.

Authors:  B B Perlman; L R Freedman
Journal:  Yale J Biol Med       Date:  1971-10
  8 in total
  9 in total

Review 1.  Chemoprophylaxis.

Authors:  L P Garrod
Journal:  Br Med J       Date:  1975-12-06

2.  Editorial: Antibiotic cover for dental extraction.

Authors: 
Journal:  Br Med J       Date:  1975-07-26

Review 3.  Antibiotic tolerance among clinical isolates of bacteria.

Authors:  E Tuomanen; D T Durack; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

4.  Current practice in prevention of bacterial endocarditis.

Authors:  D T Durack
Journal:  Br Heart J       Date:  1975-05

5.  Antibiotics for streptococcal endocarditis.

Authors:  S W Newsom
Journal:  Thorax       Date:  1980-05       Impact factor: 9.139

6.  Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.

Authors:  L L Pelletier; D T Durack; R G Petersdorf
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

7.  Natural history of aortic valve endocarditis in rats.

Authors:  E Héraïef; M P Glauser; L R Freedman
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

8.  Vancomycin prophylaxis of experimental Streptococcus sanguis. Inhibition of bacterial adherence rather than bacterial killing.

Authors:  J P Bernard; P Francioli; M P Glauser
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Experimental endocarditis: prophylaxis of Candida albicans infections by 5-fluorocytosine in rabbits.

Authors:  G Demierre; L R Freedman
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.